Us Breaking News Novo Nordisk Warns Consumers About Counterfeit Versions Of Ozempic In Us

Counterfeit Ozempic found in US drug supply, FDA warns

As Ozempic and other drugs used for weight loss continue to soar in popularity, the U.S. Food and Drug Administration (FDA) has issued a new warning for consumers. On Thursday, the FDA announced it ... Read More

Novo Nordisk to offer select doses of Ozempic, Wegovy at a steep discount

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month. Then the monthly cost will rise to $349. Read More

Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic for some customers

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly. Read More

Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay in US

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the US market ... Read More

Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ... Read More

Drugmaker cuts prices for Ozempic, Wegovy. Here's how much you will pay.

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications. Read More

Novo Nordisk Slashes Wegovy And Ozempic Prices Amid Trump Pressure And Competition

Novo Nordisk announced Monday that it is significantly cutting the prices of its blockbuster GLP-1 drugs, Wegovy (for weight loss) and Ozempic (for diabetes), for cash-paying patients in the United ... Read More

Novo Nordisk accepts Ozempic, Wegovy and Rybelsus prices in US Medicare negotiations

LONDON (Reuters) -Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes and obesity medicines Ozempic, Wegovy and Rybelsus, which ... Read More

Novo Nordisk Strikes US Medicare Price Deal

LONDON (Reuters) -Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in its key drugs Ozempic and Wegovy, in a deal that some ... Read More

Ozempic Maker Novo Nordisk Lowers Growth Outlook

Novo Nordisk NOVO.B1.57%increase; green up pointing triangle lowered its sales and profit guidance as the pharmaceutical company contends with intensifying competition, pricing pressure and copycat ... Read More